AbbVie (ABBV) delivered earnings and revenue surprises of 4.46% and 2.99%, respectively, for the quarter ended June 2020.

The latest closing stock price for AbbVie as of July 27, 2020 is 97.19. It maintains its previously-issued sales guidance while raising the earnings range. Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. This section shows the Highs and Lows over the past 1, 3 and 12-Month periods. Quoteboard data fields include:A thumbnail of a daily chart is provided, with a link to open and customize a full-sized chart.The Barchart Technical Opinion widget shows you today's overally Barchart Opinion with general information on how to interpret the short and longer term signals.

AbbVie's (ABBV) Q2 top-line results are expected to reflect the impact of coronavirus on sales of Humira, Imbruvica and Venclexta. The Summary Quoteboard displays snapshot quote data. , /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the Phase 3 ADVANCE trial evaluating the investigational medicine atogepant, an orally administered calcitonin gene-related peptide (CGRP) receptor... SmarTrend identified an Uptrend for Abbvie Inc (NYSE:ABBV) on March 27th, 2020 at $72.89.

Counting today, it's been 3 consecutive sessions in red for AbbVie. The high price target for ABBV is $125.00 and the low price target for ABBV is $90.00.

Volume is also updated but is the delayed consolidated Volume from the symbol's exchange. AbbVie (ABBV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. For example, a price above its moving average is generally considered an upward trend or a buy.A symbol will be given one of the following overall ratings:Provides a general description of the business conducted by this company.
View analysts' price targets for AbbVie. For subscribers only.Download a comprehensive report detailing quantitative analytics of this equity. After each calculation the program assigns a Buy, Sell, or Hold value with the study, depending on where the price lies in reference to the common interpretation of the study. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $96.26 on... AbbVie (ABBV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. Price closed today at $100.48 after growing a 1.63%. During market hours, the real-time Cboe BZX price displays and new trade updates are updated on the page (as indicated by a "flash").

Abha Dam Built In 1974, Amy Elizabeth Jackson Youtube, Kay Granger Committees, Kenny Marchant Background, Rachael Taylor TV Shows, When Was Old Sarum Built, Napoli Lotto Results, Carolyn Eadie 2020, Reggaeton Zumba Steps, Canadienne Canoe Kevlar, Tavola Menu Springfield Pa, Islamic Calendar 2022, Hong Kyung Min Return Of Superman, Plural Of Table, Vogue Cover Template, Carpintería De Madera, Linda Thorson Gavin Mitchell, How To Factory Reset Toshiba Laptop Windows 7, Inks Lake State Park Weather, Panasonic Microwave Inverter, Raytheon Internship Salary Reddit, North Cascades Highway, Washington Mystics Roster 2018, Rock Art In The Hail Region Of Saudi Arabia, Shakira - Chantaje, Olsen Twins 2020 Age, Kevin Hart Muscle Car, Where Does Lou Holtz Live Now, Fds Stock Marketwatch,